Interview: Steve Bates – CEO, BioIndustry Association (BIA), UK
Steve Bates, CEO of the UK BioIndustry Association (BIA) for over five years, shares the importance of the UK’s status as a global life science hub, the long-term government actions…
Address: 13 Windsor Street, Islington, London N1 8QG,United Kingdom
Tel: +44(0)20 7288 7008
An elegant corporate events venue for business meetings & private conferences in Islington, London.
Many clients comment on how well their functions turn out at The Window. The combination of the light, spacious ambience and the friendly, responsive events team, allows clients to step out of the ordinary “conference mode” and encourages creative thinking and open dialogue.
Whether it’s for a business conference, a product launch, training seminar or executive meeting, the flexible floor spaces add that extra imaginative flair and the personalised client service takes care of the details to ensure an event is a complete success.
Venu hire for corporate events or private events.
The Window offers four distinctive and complementary floor spaces with eight rooms to suit varying needs. The elegant entrance way, flanked by a rock garden and over-hanging balcony, welcomes clients into a light and spacious two tiered reception floor.
The top floor conference room provides the focal point for the event. Its panoramic view of the London skyline and trade mark 12ft window make this an impressive backdrop for corporate presentations. Third floor executive suite and meeting rooms are ideal for smaller meetings and presentations. Audio Visual Services are also available on request.
The dining area, supported by specialist in-house catering services, can also be used as a secondary conference floor. Its more informal and relaxed environment lends itself to break out groups, private meetings and informal gatherings. Additional private rooms are also available upon request.
The Window’s prime location is supported by good transport links with Angel and Highbury & Islington underground stations and an NCP car park, all within a 10 minute walk. Wheelchair access is provided to all floors and The Hilton Hotel is close by for delegates requiring overnight accommodation.
Steve Bates, CEO of the UK BioIndustry Association (BIA) for over five years, shares the importance of the UK’s status as a global life science hub, the long-term government actions…
After a series of recent acquisitions, developing a diverse portfolio comprising four business areas; including OTC and branded prescription medicines, Mylan UK’s country manager, Jean-Yves Brault, takes a step back…
Hugo Fry, managing director of Sanofi UK, details the impact of the company’s changing structure, the continued relevance of the UK market despite the challenges around Brexit, and the significance…
With an appetite to take the next step in its rapid development, EUSA Pharma has already established itself as a leading rare-disease and oncology biotech company in just a short…
Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry (ABPI) reveals his staunch faith in the British health service but calls for the NHS to welcome and…
Liam O’Toole, CEO of Arthritis Research UK, discusses how arthritis impacts the British economy, raising public awareness of the condition, the potential ramifications of Brexit, and the importance of inter-stakeholder…
Mark Hicken, managing director of the UK and Ireland operations of Janssen, the pharmaceutical arm of Johnson & Johnson, highlights the company’s long-standing R&D presence in the UK. He calls…
Sir Robert Lechler, president of the Academy of Medical Sciences (AMS), discusses the Academy’s role in promoting medical research in the UK and how that stands to change in the…
Keith Thompson, CEO of the Cell & Gene Therapy Catapult, one of a number of Catapult institutions in the UK designed to help commercialize innovative research, discusses strategy, funding, international…
Terry O’Regan, VP and managing director at Biogen UK and Ireland, discusses the company’s longstanding commitment to the UK, market access issues, and why Biogen is staying the course with…
Sir John Savill, chief executive of the Medical Research Council between 2010 and 2018, discusses the organization’s transition into part of the new UK Research and Innovation (UKRI) grouping, the…
Steve Ford, CEO of Parkinson’s UK, one of the UK’s leading research-based charities, discusses his organization’s recent Digital Leadership Award, presenting the needs of Parkinson’s patients to stakeholders, and why…
See our Cookie Privacy Policy Here
